<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00179127</url>
  </required_header>
  <id_info>
    <org_study_id>040643</org_study_id>
    <nct_id>NCT00179127</nct_id>
  </id_info>
  <brief_title>Use of Insulin Glargine to Treat Diabetic Ketoacidosis</brief_title>
  <official_title>Early Use of Insulin Glargine in Diabetic Ketoacidosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of the addition of insulin glargine
      during the early phase of moderate to severe Diabetic Ketoacidosis (DKA) in children.

      The investigators hypothesize that the addition of insulin glargine during the early phase of
      management of DKA will accelerate acidosis correction, decrease the length of insulin
      infusion, and decrease the total intensive care unit time in children admitted to the ICU.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time of Acidosis Correction</measure>
    <time_frame>Minutes</time_frame>
    <description>Unable to find any data on this study. PI left Vanderbilt and there was not a publication.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time on Insulin Drip</measure>
    <time_frame>Minutes</time_frame>
    <description>Unable to find any data on this study. PI left Vanderbilt and there was not a publication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Hospital Stay</measure>
    <time_frame>Days</time_frame>
    <description>Unable to find any data on this study. PI left Vanderbilt and there was not a publication.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Diabetic Ketoacidosis</condition>
  <arm_group>
    <arm_group_label>Glargine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.3u/kg of glargine, subcutaneously, once</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.3u/kg of saline, subcutaneously, once</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>glargine</intervention_name>
    <description>0.3u/kg of glargine, subcutaneously, once</description>
    <arm_group_label>Glargine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>0.3u/kg of saline, subcutaneously, once</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 6-18 y.o. presenting to Vanderbilt Children's Hospital (VCH) Emergency Room with:

          -  Established history of insulin dependent diabetes

        AND:

          -  Chief c/o hyperglycemia or vomiting

          -  Venous pH &lt; 7.24

          -  Serum Bicarbonate &lt; 18

          -  Blood glucose &gt; 150

          -  Urinary Ketones

        Exclusion Criteria:

          -  Age &lt; 6y.o.

          -  New onset diabetes

          -  Received IV insulin bolus prior to arrival to VCH Emergency Room (ER)

          -  Venous pH &gt; 7.24

          -  Serum Bicarbonate &gt; 18

          -  Pregnancy

          -  Received glargine within 12 hours prior to arrival to VCH Emergency Room/Pediatric
             Critical Care Unit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sheila McMorrow, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Monroe Carell Children's Hospital</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <results_first_submitted>April 2, 2018</results_first_submitted>
  <results_first_submitted_qc>June 12, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">July 16, 2018</results_first_posted>
  <last_update_submitted>June 12, 2018</last_update_submitted>
  <last_update_submitted_qc>June 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pediatrics</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Emergency Care</keyword>
  <keyword>Endocrinology</keyword>
  <keyword>Critical Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketosis</mesh_term>
    <mesh_term>Acidosis</mesh_term>
    <mesh_term>Diabetic Ketoacidosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Glargine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Original data cannot be found. PI has left Vanderbilt and does not know where records are located. Total enrollment and completion date was obtained from Institutional Review Board records.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Glarine</title>
          <description>glargine: 0.3u/kg of glargine, subq, once</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>saline: 0.3cc/kg of saline, subq, once</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Glargine</title>
          <description>0.3u/kg of glargine, subcutaneously, once
glargine: 0.3u/kg of glargine, subcutaneously, once</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>0.3u/kg of saline, subcutaneously, once
saline: 0.3u/kg of saline, subcutaneously, once</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="0"/>
            <count group_id="B2" value="0"/>
            <count group_id="B3" value="0"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                </category>
                <category>
                  <title>Male</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <class_list>
            <class>
              <title>United States</title>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time of Acidosis Correction</title>
        <description>Unable to find any data on this study. PI left Vanderbilt and there was not a publication.</description>
        <time_frame>Minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Glarine</title>
            <description>glargine: 0.3u/kg of glargine, subq, once</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>saline: 0.3cc/kg of saline, subq, once</description>
          </group>
        </group_list>
        <measure>
          <title>Time of Acidosis Correction</title>
          <description>Unable to find any data on this study. PI left Vanderbilt and there was not a publication.</description>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time on Insulin Drip</title>
        <description>Unable to find any data on this study. PI left Vanderbilt and there was not a publication.</description>
        <time_frame>Minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Glarine</title>
            <description>glargine: 0.3u/kg of glargine, subq, once</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>saline: 0.3cc/kg of saline, subq, once</description>
          </group>
        </group_list>
        <measure>
          <title>Time on Insulin Drip</title>
          <description>Unable to find any data on this study. PI left Vanderbilt and there was not a publication.</description>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Hospital Stay</title>
        <description>Unable to find any data on this study. PI left Vanderbilt and there was not a publication.</description>
        <time_frame>Days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Glarine</title>
            <description>glargine: 0.3u/kg of glargine, subq, once</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>saline: 0.3cc/kg of saline, subq, once</description>
          </group>
        </group_list>
        <measure>
          <title>Total Hospital Stay</title>
          <description>Unable to find any data on this study. PI left Vanderbilt and there was not a publication.</description>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Unable to find any data on this study. PI left Vanderbilt and there was not a publication.</desc>
      <group_list>
        <group group_id="E1">
          <title>Glarine</title>
          <description>glargine: 0.3u/kg of glargine, subq, once</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>saline: 0.3cc/kg of saline, subq, once</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sheila McMorrow</name_or_title>
      <organization>Vanderbilt University Medical Center</organization>
      <phone>615-343-8332</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

